Literature DB >> 12085653

Applying wavefront sensors and corneal topography to keratoconus.

Jason Marsack1, Thomas Milner, Grady Rylander, Norman Leach, Austin Roorda.   

Abstract

We report preliminary results from a study to create custom optics (contact lenses) for persons with the eye disease Keratoconus. Custom optics are intended to correct for higher order aberrations which cannot currently be corrected with conventional contact lenses. A lens design algorithm has been developed that utilizes both wavefront sensor data and corneal topography data. The lenses will be formed from thick, pre-fabricated soft contact lenses using laser ablation. Preliminary ablation of these lenses is demonstrated using a femptosecond Ti: Sapphire (Ti:Al2O3) laser system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12085653

Source DB:  PubMed          Journal:  Biomed Sci Instrum        ISSN: 0067-8856


  5 in total

1.  Impact of Zernike-fit error on simulated high- and low-contrast acuity in keratoconus: implications for using Zernike-based corrections.

Authors:  Jason D Marsack; Konrad Pesudovs; Edwin J Sarver; Raymond A Applegate
Journal:  J Opt Soc Am A Opt Image Sci Vis       Date:  2006-04       Impact factor: 2.129

2.  Method for expressing clinical and statistical significance of ocular and corneal wave front error aberrations.

Authors:  Michael K Smolek
Journal:  Cornea       Date:  2012-03       Impact factor: 2.651

3.  Performance of wavefront-guided soft lenses in three keratoconus subjects.

Authors:  Jason D Marsack; Katrina E Parker; Raymond A Applegate
Journal:  Optom Vis Sci       Date:  2008-12       Impact factor: 1.973

Review 4.  Adaptive optics technology for high-resolution retinal imaging.

Authors:  Marco Lombardo; Sebastiano Serrao; Nicholas Devaney; Mariacristina Parravano; Giuseppe Lombardo
Journal:  Sensors (Basel)       Date:  2012-12-27       Impact factor: 3.576

5.  Normal and diseased personal eye modeling using age-appropriate lens parameters.

Authors:  Ying-Ling Chen; L Shi; J W L Lewis; M Wang
Journal:  Opt Express       Date:  2012-05-21       Impact factor: 3.894

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.